Stockhouse32m
MQ DEADLINE NOTICE: A Class Action was filed on behalf of Marqeta, Inc. Shareholders - Contact BFA Law if You Lost Money before Court Deadline
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Marqeta, Inc. (NASDAQ:MQ) and certain of the ...
Stockhouse32m
PACS DEADLINE NOTICE: A Class Action was filed on behalf of PACS Group Shareholders - Contact BFA Law if You Lost Money before Court Deadline
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE:PACS) and certain of the ...
Stockhouse47m
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Informa TechTarget - TTGT
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Informa TechTarget ("Informa" or the "Company") (NASDAQ:TTGT). Such investors are ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Shareholders
NDAQ:KYTX) Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Shareholders ...
Shareholders That Lost Money on Wolfspeed, Inc. (WOLF) Should Contact Levi & Korsinsky About Pending Class Action - WOLF
THE LAWSUIT: A class action securities lawsuit was filed against Wolfspeed, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 16, ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ:BIOA). Such investors are advised ...
Shareholder Rights Advocates at Levi & Korsinsky Investigate Keros Therapeutics, Inc. (KROS) Regarding Possible Securities Fraud Violations
NDAQ:KROS) Shareholder Rights Advocates at Levi & Korsinsky Investigate Keros Therapeutics, Inc. (KROS) Regarding Possible Securities Fraud Violations ...
$10M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
The gross proceeds of the offering will be approximately $10 million before deducting placement agent fees and other estimated offering expenses payable by the company. The closing of the offering is ...